Katarzyna Dzitko

Deputy Dean of the Faculty of Biology and Environmental Protection / PhD, DSc, Assoc. Prof. (ENG) dr hab. prof. nadzw. UŁ (PL) / Director of the BioMedChem Doctoral School of the UL and Lodz Institutes of the Polish Academy of Science

University of Łódź

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Katarzyna Dzitko is an Associate Professor and Deputy Dean of the Faculty of Biology and Environmental Protection at the University of Łódź, Poland. She also serves as the Director of the BioMedChem Doctoral School of the University of Łódź and the Lodz Institutes of the Polish Academy of Science. Her research focuses on microbiology and pharmacology, particularly the application of postbiotics in cancer treatment, immunity against Toxoplasma gondii, and anti-mycobacterial agents.

Articles (13)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (22)

Bartłomiej Ferra

assistant professor

University of Gdańsk

POLAND

Katarzyna Dzitko

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Lactic Acid Bacteria-Derived Postbiotics as Adjunctive Agents in Breast Cancer Treatment to Boost the Antineoplastic Effect of a Conventional Therapeutic Comprising Tamoxifen and a New Drug Candidate: An Aziridine–Hydrazide Hydrazone Derivative

TZD-Based Hybrid Molecules Act as Dual Anti-Mycobacterium tuberculosis and Anti-Toxoplasma gondii Agents

Evaluation of long-term immunity and protection against T. gondii after immunization with multivalent recombinant chimeric T. gondii proteins

The functional response of human monocyte-derived macrophages to serum amyloid A and Mycobacterium tuberculosis infection

Inhibition of Toxoplasma gondii by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazine

4-Arylthiosemicarbazide derivatives – Pharmacokinetics, toxicity and anti-Toxoplasma gondii activity in vivo

4-Arylthiosemicarbazide Derivatives as Toxoplasmic Aromatic Amino Acid Hydroxylase Inhibitors and Anti-inflammatory Agents

Imidazole-Thiosemicarbazide Derivatives as Potent Anti-Mycobacterium tuberculosis Compounds with Antibiofilm Activity

Mycobacterium tuberculosis Binds Human Serum Amyloid A, and the Interaction Modulates the Colonization of Human Macrophages and the Transcriptional Response of the Pathogen

1,3,4-Thiadiazoles Effectively Inhibit Proliferation of <i>Toxoplasma gondii</i>

4-Arylthiosemicarbazide derivatives as a new class of tyrosinase inhibitors and anti-Toxoplasma gondii agents

The Immunogenic and Immunoprotective Activities of Recombinant Chimeric T. gondii Proteins Containing AMA1 Antigen Fragments

Toxoplasma gondii Recombinant antigen AMA1: Diagnostic Utility of Protein Fragments for the Detection of IgG and IgM Antibodies

Collaborators (22)

Bartłomiej Ferra

Barbara Kaproń

Monika Witusik-Perkowska

Grażyna Chwatko

Adrian Bekier

Agata Paneth

Łukasz Albrecht

Jakub Kryczka

Tomasz Plech

Radoslaw Bednarek

Barbara Pacholczyk-Sienicka

Justyna Gatkowska

Adam Pieczonka

Malwina Kawka

Lucyna Holec-Gąsior

Jakub Lach

Piotr Paneth

Marcin Słomka

Bozena Dziadek

Jaroslaw Dziadek

Nazar Trotsko

Przemyslaw Plocinski

Make your next move.